NCT05319639 2025-02-27Phase I/II Study of the Combination of Irinotecan and POF (POFI) and TislelizumabFujian Cancer HospitalPhase 1/2 Recruiting51 enrolled
NCT05608785 2022-11-08Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different GenotypesHenan Cancer HospitalPhase 1/2 Unknown45 enrolled